JADA 2018-001 JADA vs J-5973

In July 2018 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the cyclist J-5973 after his sample tested positive for the prohibited substances Clomiphene and Metandienone. After notification the Athlete admitted the violation, waived his right to be heard, accepted the test result, a provisional suspension and the sanction proposed by JADA.

JADA considers that the Athlete could not explain how the prohibited substance entered his system nor that the violation was not intentional. Therefore JADA decides on 31 July 2018 to impose a 4 year period of ineligibility on the Athlete J-5973 starting on the date of the provisional suspension, i.e. on 11 July 2018.

Original document

Parameters

Legal Source
National Decisions
Settlement
Date
31 July 2018
Arbitrator
Suzuki, Hidenori
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Settlement
Waiver of "right to be heard"
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Japan Anti-Doping Agency (JADA)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Clomifene
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Document type
Pdf file
Date generated
10 July 2019
Date of last modification
23 March 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin